Contraceptive Devices Market: By Product Type (Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms & Sponges, Vaginal Rings, Intrauterine Devices, Sub-dermal Implants, Others), By Technology (Hormonal Contraceptives, Barrier Contraceptives), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO, Others), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
Contraceptive Devices Market: By Product Type (Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms & Sponges, Vaginal Rings, Intrauterine Devices, Sub-dermal Implants, Others), By Technology (Hormonal Contraceptives, Barrier Contraceptives), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO, Others), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
PRODUCT OVERVIEW
A method or equipment used to prevent pregnancy is known as birth control, sometimes known as contraception, fertility control, or anti-conception. Sterilization through vasectomy in males and tubal ligation in females, implanted birth control, and intrauterine devices are the most effective methods of birth control (IUDs). Some cultures prohibit or restrict access to birth control as it is morally, religiously, or politically objectionable to them. The phrase 'birth control' is a bit of a misnomer as it does not usually include abortion.
MARKET HIGHLIGHTS
Global Contraceptive Devices Market is expected to reach a notable CAGR of 6.4% by the end of 2031
Global Contraceptive Devices Market to surpass USD 34.3 billion by 2031 from USD 18.4 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-2031. Strong government promotions and programs for women's and children's health can be attributed to factors such as the increased use of contraceptive devices. Government involvement in promoting family planning and contraception, particularly in developing countries, is a crucial element driving the global contraceptive devices industry. Growing contraception awareness and the availability of effective contraception options are also key factors in country pregnancy and birth rates.
GLOBAL CONTRACEPTIVE DEVICES MARKET: SEGMENTS
Hormonal Contraceptives segment is predicted to lead with the highest CAGR during 2021-31
Based on Technology, the global Contraceptive Devices Market is fragmented into Hormonal Contraceptives, and Barrier Contraceptives. Hormonal contraceptives and barrier contraceptives make up the worldwide contraceptive devices market. Hormonal contraceptives have been anticipated to lead the market in terms of revenue in recent years, and this trend is expected to continue in the future due to increased preference and efficiency.
Hospital segment is expected to capture considerable growth with the highest CAGR during 2021-31
Global Contraceptive Devices Market is classified on the basis of Distribution Channel into Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO, and Others. Owing to the increased use of implantable contraceptive devices by healthcare professionals and active government backing for contraceptive distribution through government-assisted hospitals around the world, hospital pharmacies are a key source of contraceptive devices. The market for contraceptives is predicted to rise significantly in the next years due to rising demand.
MARKET DYNAMICS
Drivers
Growing focus on the need for family planning and avoiding unwanted pregnancy
Rising awareness about the contraceptive products
Restraint
Side effects associated with the Contraceptive Devices
GLOBAL CONTRACEPTIVE DEVICES MARKET:
Key Players
Contraceptive Devices Market Segments:
PRODUCT OVERVIEW
A method or equipment used to prevent pregnancy is known as birth control, sometimes known as contraception, fertility control, or anti-conception. Sterilization through vasectomy in males and tubal ligation in females, implanted birth control, and intrauterine devices are the most effective methods of birth control (IUDs). Some cultures prohibit or restrict access to birth control as it is morally, religiously, or politically objectionable to them. The phrase 'birth control' is a bit of a misnomer as it does not usually include abortion.
MARKET HIGHLIGHTS
Global Contraceptive Devices Market is expected to reach a notable CAGR of 6.4% by the end of 2031
Global Contraceptive Devices Market to surpass USD 34.3 billion by 2031 from USD 18.4 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-2031. Strong government promotions and programs for women's and children's health can be attributed to factors such as the increased use of contraceptive devices. Government involvement in promoting family planning and contraception, particularly in developing countries, is a crucial element driving the global contraceptive devices industry. Growing contraception awareness and the availability of effective contraception options are also key factors in country pregnancy and birth rates.
GLOBAL CONTRACEPTIVE DEVICES MARKET: SEGMENTS
Hormonal Contraceptives segment is predicted to lead with the highest CAGR during 2021-31
Based on Technology, the global Contraceptive Devices Market is fragmented into Hormonal Contraceptives, and Barrier Contraceptives. Hormonal contraceptives and barrier contraceptives make up the worldwide contraceptive devices market. Hormonal contraceptives have been anticipated to lead the market in terms of revenue in recent years, and this trend is expected to continue in the future due to increased preference and efficiency.
Hospital segment is expected to capture considerable growth with the highest CAGR during 2021-31
Global Contraceptive Devices Market is classified on the basis of Distribution Channel into Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO, and Others. Owing to the increased use of implantable contraceptive devices by healthcare professionals and active government backing for contraceptive distribution through government-assisted hospitals around the world, hospital pharmacies are a key source of contraceptive devices. The market for contraceptives is predicted to rise significantly in the next years due to rising demand.
MARKET DYNAMICS
Drivers
Growing focus on the need for family planning and avoiding unwanted pregnancy
Rising awareness about the contraceptive products
Restraint
Side effects associated with the Contraceptive Devices
GLOBAL CONTRACEPTIVE DEVICES MARKET:
Key Players
- Bayer AG
- Pfizer Inc.
- Janssen Global Services, LLC
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Allergan Reckitt Benckiser Group plc
- Veru Inc.
- Church & Dwight Co., Inc.
- Medisafe Distribution Inc.
- Other Prominent Players
Contraceptive Devices Market Segments:
- By Product Type
- Male Contraceptive Devices
- Female Contraceptive Devices
- Female Condoms
- Diaphragms & Sponges
- Vaginal Rings
- Intrauterine Devices
- Sub-dermal Implants
- Others
- By Technology
- Hormonal Contraceptives
- Barrier Contraceptives
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Clinics
- Online Channels
- Public Channel & NGO
- Others
- Contraceptive Devices Market Dynamics
- Contraceptive Devices Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Global Contraceptive Devices Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Global Contraceptive Devices Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 GLOBAL CONTRACEPTIVE DEVICES MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 GLOBAL CONTRACEPTIVE DEVICES MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 GLOBAL CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. Male Contraceptive Devices
11.3.1.1.1. By Value (USD Million) 2021-2031F
11.3.1.1.2. Market Share (%) 2021-2031F
11.3.1.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.2. Female Contraceptive Devices
11.3.1.2.1. By Value (USD Million) 2021-2031F
11.3.1.2.2. Market Share (%) 2021-2031F
11.3.1.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.3. Female Condoms
11.3.1.3.1. By Value (USD Million) 2021-2031F
11.3.1.3.2. Market Share (%) 2021-2031F
11.3.1.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.4. Diaphragms & Sponges
11.3.1.4.1. By Value (USD Million) 2021-2031F
11.3.1.4.2. Market Share (%) 2021-2031F
11.3.1.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.5. Vaginal Rings
11.3.1.5.1. By Value (USD Million) 2021-2031F
11.3.1.5.2. Market Share (%) 2021-2031F
11.3.1.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.6. Intrauterine Devices
11.3.1.6.1. By Value (USD Million) 2021-2031F
11.3.1.6.2. Market Share (%) 2021-2031F
11.3.1.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.7. Sub-dermal Implants
11.3.1.7.1. By Value (USD Million) 2021-2031F
11.3.1.7.2. Market Share (%) 2021-2031F
11.3.1.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.8. Others
11.3.1.8.1. By Value (USD Million) 2021-2031F
11.3.1.8.2. Market Share (%) 2021-2031F
11.3.1.8.3. Y-o-Y Growth (%) 2021-2031F
11.3.2. By Distribution Channel
11.3.2.1. Hospital Pharmacy
11.3.2.1.1. By Value (USD Million) 2021-2031F
11.3.2.1.2. Market Share (%) 2021-2031F
11.3.2.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.2. Retail Pharmacy
11.3.2.2.1. By Value (USD Million) 2021-2031F
11.3.2.2.2. Market Share (%) 2021-2031F
11.3.2.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.3. Clinics
11.3.2.3.1. By Value (USD Million) 2021-2031F
11.3.2.3.2. Market Share (%) 2021-2031F
11.3.2.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.4. Online Channel
11.3.2.4.1. By Value (USD Million) 2021-2031F
11.3.2.4.2. Market Share (%) 2021-2031F
11.3.2.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.5. Public Channel
11.3.2.5.1. By Value (USD Million) 2021-2031F
11.3.2.5.2. Market Share (%) 2021-2031F
11.3.2.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.6. Others
11.3.2.6.1. By Value (USD Million) 2021-2031F
11.3.2.6.2. Market Share (%) 2021-2031F
11.3.2.6.3. Y-o-Y Growth (%) 2021-2031F
12 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By Distribution Channel
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Bayer AG
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Pfizer Inc.
18.3. Janssen Global Services, LLC
18.4. Teva Pharmaceutical Industries Ltd.
18.5. Merck & Co., Inc.
18.6. Mylan N.V.
18.7. Allergan Reckitt Benckiser Group plc
18.8. Veru Inc.
18.9. Church & Dwight Co., Inc.
18.10. Medisafe Distribution Inc
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2. Business Trends
1.3. Global Contraceptive Devices Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Global Contraceptive Devices Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 GLOBAL CONTRACEPTIVE DEVICES MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 GLOBAL CONTRACEPTIVE DEVICES MARKET
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 GLOBAL CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. Male Contraceptive Devices
11.3.1.1.1. By Value (USD Million) 2021-2031F
11.3.1.1.2. Market Share (%) 2021-2031F
11.3.1.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.2. Female Contraceptive Devices
11.3.1.2.1. By Value (USD Million) 2021-2031F
11.3.1.2.2. Market Share (%) 2021-2031F
11.3.1.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.3. Female Condoms
11.3.1.3.1. By Value (USD Million) 2021-2031F
11.3.1.3.2. Market Share (%) 2021-2031F
11.3.1.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.4. Diaphragms & Sponges
11.3.1.4.1. By Value (USD Million) 2021-2031F
11.3.1.4.2. Market Share (%) 2021-2031F
11.3.1.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.5. Vaginal Rings
11.3.1.5.1. By Value (USD Million) 2021-2031F
11.3.1.5.2. Market Share (%) 2021-2031F
11.3.1.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.6. Intrauterine Devices
11.3.1.6.1. By Value (USD Million) 2021-2031F
11.3.1.6.2. Market Share (%) 2021-2031F
11.3.1.6.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.7. Sub-dermal Implants
11.3.1.7.1. By Value (USD Million) 2021-2031F
11.3.1.7.2. Market Share (%) 2021-2031F
11.3.1.7.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.8. Others
11.3.1.8.1. By Value (USD Million) 2021-2031F
11.3.1.8.2. Market Share (%) 2021-2031F
11.3.1.8.3. Y-o-Y Growth (%) 2021-2031F
11.3.2. By Distribution Channel
11.3.2.1. Hospital Pharmacy
11.3.2.1.1. By Value (USD Million) 2021-2031F
11.3.2.1.2. Market Share (%) 2021-2031F
11.3.2.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.2. Retail Pharmacy
11.3.2.2.1. By Value (USD Million) 2021-2031F
11.3.2.2.2. Market Share (%) 2021-2031F
11.3.2.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.3. Clinics
11.3.2.3.1. By Value (USD Million) 2021-2031F
11.3.2.3.2. Market Share (%) 2021-2031F
11.3.2.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.4. Online Channel
11.3.2.4.1. By Value (USD Million) 2021-2031F
11.3.2.4.2. Market Share (%) 2021-2031F
11.3.2.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.5. Public Channel
11.3.2.5.1. By Value (USD Million) 2021-2031F
11.3.2.5.2. Market Share (%) 2021-2031F
11.3.2.5.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.6. Others
11.3.2.6.1. By Value (USD Million) 2021-2031F
11.3.2.6.2. Market Share (%) 2021-2031F
11.3.2.6.3. Y-o-Y Growth (%) 2021-2031F
12 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By Distribution Channel
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA CONTRACEPTIVE DEVICES MARKET SIZE & FORECAST 2021A-2031F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Bayer AG
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Pfizer Inc.
18.3. Janssen Global Services, LLC
18.4. Teva Pharmaceutical Industries Ltd.
18.5. Merck & Co., Inc.
18.6. Mylan N.V.
18.7. Allergan Reckitt Benckiser Group plc
18.8. Veru Inc.
18.9. Church & Dwight Co., Inc.
18.10. Medisafe Distribution Inc
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
